# US 2021/0172023 A1 · Synthetic nucleic acid control molecules

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0172023 A1
- Document ID: US20210172023A1
- Status: Published application
- Kind: A1
- Application number: 17/110,985
- Filed: 2020-12-03
- Published: 2021-06-10
- Earliest claimed: 2013-12-19
- Assignees: Exact Sciences Development Company, LLC
- Applicants: Exact Sciences Development Company, LLC
- Inventors: Ilse A. Tyler; Keith Yaeger; Michael J. Domanico; Hatim Allawi; Graham P. Lidgard
- Web page: https://patentgrep.com/patent/US20210172023A1

## CPC

- C12Q 1/6886: for cancer (immunoassay for cancer G01N33/575)
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 2600/154: Methylation markers
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/166: Oligonucleotides used as internal standards, controls or normalisation probes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides synthetic DNA strands that find use as controls or in nucleic acid testing methods. In particular, provided herein are synthetic DNA strands of known composition for use as control molecules in stool DNA testing, e.g., of mutations and/or methylation of DNA isolated from stool samples.

## Claims

### Claim at position 1

1-78. (canceled)

### Claim 79

A run control composition, comprising:
a) a number of copies of a first synthetic DNA fragment, comprising:
i) a methylation footprint nucleotide sequence of a human gene, the methylation footprint nucleotide sequence in said first synthetic DNA fragment comprising a pattern of cytosines, wherein each of the cytosines within the methylation footprint nucleotide sequence comprises a 5-methyl, and
ii) a capture footprint nucleotide sequence;
and
b) a number of copies of a second synthetic DNA fragment comprising:
i) the methylation footprint nucleotide sequence of the human gene, the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprising the same number and pattern of cytosines as the methylation footprint nucleotide sequence in the first synthetic DNA fragment, wherein none of the cytosines within the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprises a 5-methyl, and
ii) the capture footprint nucleotide sequence;
wherein a ratio of the number of copies of the first synthetic DNA fragment to the number of copies of the second synthetic DNA fragment in the run control composition produces a run control expected result when assayed in a methylation assay.

### Claim 80 (depends on 79)

The run control composition of claim 79, wherein the first synthetic DNA fragment and the second synthetic DNA fragment are double-stranded.

### Claim 81 (depends on 79)

The run control composition of claim 79, wherein the methylation assay comprises processing DNA with a capture reagent.

### Claim 82 (depends on 79)

The run control composition of claim 79, wherein the methylation assay is a diagnostic assay that provides a diagnostic result from a DNA test sample by measuring a ratio of an amount of the human gene in the DNA test sample that is methylated in the methylation assay footprint nucleotide sequence to an amount of the gene in the DNA test sample that is not methylated in the methylation assay footprint nucleotide sequence.

### Claim 83 (depends on 82)

The run control composition of claim 82, wherein a ratio in a DNA test sample above a cutoff value measured by the diagnostic assay is indicative of a disease state in the human subject.

### Claim 84 (depends on 83)

The run control composition of claim 83, wherein the ratio of the number of copies of the first synthetic DNA fragment to the number of copies of the second synthetic DNA fragment in the run control composition is above said cutoff value.

### Claim 85 (depends on 79)

The run control composition of claim 79, further comprising a capture reagent comprising a capture probe configured to hybridize to the capture footprint nucleotide sequence.

### Claim 86 (depends on 85)

The run control composition of claim 85, wherein the capture probe is attached to a solid support.

### Claim 87 (depends on 86)

The run control composition of claim 86, wherein the solid support comprises a bead.

### Claim 88 (depends on 79)

The run control composition of claim 79, further comprising fish DNA.

### Claim 89 (depends on 79)

The run control composition of claim 79, further comprising a synthetic DNA fragment comprising a sequence from a human reference gene.

### Claim 90

A method of characterizing a DNA test sample, comprising:
A) providing a run control composition comprising:
a) a first synthetic DNA fragment, comprising:
i) a methylation footprint nucleotide sequence of a human gene, the methylation footprint nucleotide sequence in said first synthetic DNA fragment comprising a pattern of cytosines, wherein each of the cytosines within the methylation footprint nucleotide sequence comprises a 5-methyl, and
ii) a capture footprint nucleotide sequence;
and
b) a second synthetic DNA fragment comprising:
i) the methylation footprint nucleotide sequence of the human gene, the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprising the same number and pattern of cytosines as the methylation footprint nucleotide sequence in the first synthetic DNA fragment, wherein none of the cytosines within the methylation footprint nucleotide sequence in the second synthetic DNA fragment comprises a 5-methyl, and
ii) the capture footprint nucleotide sequence;
wherein a ratio of the number of copies of the first synthetic DNA fragment to the number of copies of the second synthetic DNA fragment in the run control composition produces a run control expected result when assayed in a methylation assay;
B) providing a DNA test sample isolated from a human subject;
C) applying the methylation assay to the run control composition to produce run control experimental data;
D) applying the methylation assay to the DNA test sample to produce test sample experimental data; and
E) classifying the test sample experimental data as valid if the run control experimental data are within a pre-defined acceptable range relative to the run control expected result.
wherein applying the methylation assay comprises processing the run control composition with a capture reagent comprising a capture probe that hybridizes to the capture footprint nucleotide sequence.

### Claim 91 (depends on 90)

The method of claim 90, wherein the capture probe is attached to a solid support.

### Claim 92 (depends on 91)

The method of claim 91, wherein the solid support comprises a bead.

### Claim 93 (depends on 90)

The method of claim 90, wherein the methylation assay is a diagnostic assay that provides a diagnostic result from a DNA test sample by measuring a ratio of an amount of the human gene in the DNA test sample that is methylated in the methylation assay footprint nucleotide sequence to an amount of the gene in the DNA test sample that is not methylated in the methylation assay footprint nucleotide sequence.

### Claim 94 (depends on 90)

The method of claim 90, wherein a ratio in a DNA test sample above a cutoff value measured by the diagnostic assay is indicative of a disease state in the human subject.

### Claim 95 (depends on 94)

The method of claim 94, wherein the ratio of the number of copies of the first synthetic DNA fragment to the number of copies of the second synthetic DNA fragment in the run control composition is above said cutoff value.

### Claim 96 (depends on 90)

The method of claim 90, wherein the first synthetic DNA fragment and the second synthetic DNA fragment are double-stranded.

### Claim 97 (depends on 90)

The method of claim 90, wherein the run control composition further comprises fish DNA.

### Claim 98 (depends on 90)

The method of claim 90, wherein the run control composition further comprises a synthetic DNA fragment comprising a sequence from a human reference gene.
